Official Journal of the Human Genome Organisation
Scenarioa | Cost of patient aCGH test | Cost of Targeted FISH test | Cost of MLPA test | Cost of 2 parental aCGH testsb | Total cost |
---|---|---|---|---|---|
1 No genome imbalance found; only known benign variants/polymorphisms | £446 | – | – | – | £446 |
2 Genome imbalance (deletion or duplication) found of known clinical relevance. | £446 | – | – | – | £446 |
3 Genome imbalance (deletion or duplication) found of unknownclinical relevance. Targeted FISH test performed on patient sample. Genome imbalance confirmed. Targeted FISH test on parental samples. Imbalance confirmed as inherited or ‘de novo’. | £458 | £214 c | – | – | £672 |
4 Genome imbalance (duplication only) found of unknownclinical relevance. Targeted FISH test performed on patient sample. Genome imbalance not confirmed. Targeted MLPA test on parental samples. Imbalance confirmed as inherited. | £458 | £110 | £245d | – | £813 |
5 Genome imbalance (duplication only) found of unknownclinical relevance. Targeted FISH test performed on patient sample. Genome imbalance not confirmed. Targeted MLPA test on parental samples negative. Targeted MLPA test on patient sample performed. Imbalance confirmed as ‘de novo’. | £458 | £110 | £290d | – | £858 |
6 Genome imbalance (deletion or duplication) found of unknownclinical relevance. Parental samples tested by aCGH. Imbalance confirmed as inherited | £442 | – | – | £790 | £1,232 |
7 Genome imbalance (deletion or duplication) found of unknownclinical relevance. Parental samples tested by aCGH and negative. Targeted FISH test performed on patient sample. Imbalance confirmed as ‘de novo’ | £458 | £110 | – | £790 | £1,358 |